miR-130b negatively regulates the epithelial-to-mesenchymal transition (EMT) promoting gene ZEB1. Therefore, p53-R175H exerts its prometastatic ability through the miR-130b–ZEB1 axis in endometrial-cancer cells [36]. This evidence concerns the gene TP53 and endometrial cancer.